News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
A Citi Investment Research analyst raised her price target on shares of CVS Caremark Corp. after the company received a pharmacy benefits management contract estimated at $3 billion per year.
